PHARMANAUS
ActiveSummary
PHARMANAUS has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €633,235 and a net result of -€10,886. Equity remains stable across the filed financial years (±1.1% per year). Its solvency ranks better than 68% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
12-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet -€10,886
Net result drops to -€10,886, the lowest in the series.
28-03
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
14-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
28-04
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
30-06
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial
Highest result from 2018 to 2025net €128,431 ▲345%
Operating result €207,559, net result €128,431, both a record.
31-12
Financial
Liquidity more than 22 timescurrent ratio 2.52
Current ratio from 0.11 to 2.52.
15-04
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
10-08
NBB filing
Annual accounts filed
financial year 2019 · full format · 10 days late
2019
29-04
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
03-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
21-06
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
0 of 5 deeds read
About the unread acts
We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.